These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11844631)

  • 1. Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool.
    Franck LS; Treadwell M; Jacob E; Vichinsky E
    J Pain Symptom Manage; 2002 Feb; 23(2):114-20. PubMed ID: 11844631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease.
    Taylor LE; Stotts NA; Humphreys J; Treadwell MJ; Miaskowski C
    J Pain Symptom Manage; 2010 Sep; 40(3):416-35. PubMed ID: 20656451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception of pain among pediatric patients with sickle cell pain crisis.
    Fosdal MB
    J Pediatr Oncol Nurs; 2015; 32(1):5-20. PubMed ID: 25416521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Measure of Pain Location in Adults with Sickle Cell Disease.
    Abudawood K; Yoon SL; Yao Y; Grundmann O; Ezenwa MO; Molokie RE; Wilkie DJ
    Pain Manag Nurs; 2022 Dec; 23(6):693-702. PubMed ID: 36261305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial and Functional Outcomes in Youth With Chronic Sickle Cell Pain.
    Sil S; Cohen LL; Dampier C
    Clin J Pain; 2016 Jun; 32(6):527-33. PubMed ID: 26379074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Sensory Pain, Expectation, and Satisfaction Reported by Outpatients with Cancer or Sickle Cell Disease.
    Ezenwa MO; Molokie RE; Wang ZJ; Yao Y; Suarez ML; Dyal B; Abudawood K; Wilkie DJ
    Pain Manag Nurs; 2018 Aug; 19(4):322-332. PubMed ID: 29501359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease.
    Wilkie DJ; Molokie R; Boyd-Seal D; Suarez ML; Kim YO; Zong S; Wittert H; Zhao Z; Saunthararajah Y; Wang ZJ
    J Natl Med Assoc; 2010 Jan; 102(1):18-27. PubMed ID: 20158132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidimensional assessment of pain in pediatric sickle cell disease.
    Graumlich SE; Powers SW; Byars KC; Schwarber LA; Mitchell MJ; Kalinyak KA
    J Pediatr Psychol; 2001 Jun; 26(4):203-14. PubMed ID: 11329480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Pain; 2003 Mar; 102(1-2):187-93. PubMed ID: 12620610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease.
    Ezenwa MO; Molokie RE; Wang ZJ; Yao Y; Suarez ML; Angulo V; Wilkie DJ
    J Pain Symptom Manage; 2014 Jul; 48(1):65-74. PubMed ID: 24636960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain in Children and Adolescents With Sickle Cell Disease: Multidimensional Assessment.
    Abadesso C; Pacheco S; Machado MC; Finley GA
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):455-462. PubMed ID: 32925397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of PROMIS® Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery.
    Dampier C; Jaeger B; Gross HE; Barry V; Edwards L; Lui Y; DeWalt DA; Reeve BB
    Pediatr Blood Cancer; 2016 Jun; 63(6):1038-45. PubMed ID: 26853841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining Biopsychosocial Factors in Relation to Multiple Pain Features in Pediatric Sickle Cell Disease.
    Schlenz AM; Schatz J; Roberts CW
    J Pediatr Psychol; 2016 Sep; 41(8):930-40. PubMed ID: 26869665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Geographic Characterization of 30-Day Readmissions in Pediatric Sickle Cell Crisis Patients.
    McMillan JE; Meier ER; Winer JC; Coco M; Daymont M; Long S; Jacobs BR
    Hosp Pediatr; 2015 Aug; 5(8):423-31. PubMed ID: 26231632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease.
    Raphael JL; Kamdar A; Wang T; Liu H; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Sep; 51(3):398-401. PubMed ID: 18300322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease.
    Dampier C; Barry V; Gross HE; Lui Y; Thornburg CD; DeWalt DA; Reeve BB
    Pediatr Blood Cancer; 2016 Jun; 63(6):1031-7. PubMed ID: 26895143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidimensional assessment using the adolescent pediatric pain tool: a case report.
    Crandall M; Savedra M
    J Spec Pediatr Nurs; 2005; 10(3):115-23. PubMed ID: 16083431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent pediatric pain tool for multidimensional measurement of pain in children and adolescents.
    Jacob E; Mack AK; Savedra M; Van Cleve L; Wilkie DJ
    Pain Manag Nurs; 2014 Sep; 15(3):694-706. PubMed ID: 23870767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia.
    Heath LE; Heeney MM; Hoppe CC; Adjei S; Agbenyega T; Badr M; Masera N; Zhou C; Brown PB; Jakubowski JA; Dampier C
    Clin Trials; 2017 Dec; 14(6):563-571. PubMed ID: 28743191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the sickle cell disease pain burden interview-youth.
    Zempsky WT; O'Hara EA; Santanelli JP; Palermo TM; New T; Smith-Whitley K; Casella JF
    J Pain; 2013 Sep; 14(9):975-82. PubMed ID: 23701707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.